James J. Bochnowski's most recent trade in Jaguar Health Inc was a trade of 6,363 Common Stock done . Disclosure was reported to the exchange on Dec. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 6,363 | 6,415 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 6,363 | 6,363 | - | - | Stock Option (right to buy) | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 54,786 | 27,002 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 28,388 | 28,388 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | James J. Bochnowski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2025 | 27,002 | 0 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | James J. Bochnowski | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 27,002 | 27,002 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | James J. Bochnowski | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 27,002 | 27,002 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 23,200 | 23,200 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 76,613 | 78,876 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,280 | 2,263 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,280 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 13,133 | 73,765 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | James J. Bochnowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 13,133 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | James J. Bochnowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 96,015 | 96,015 | - | - | Restricted stock units |